Poster Abstract Session:
237. Healthcare Epidemiology: HAI Surveillance
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID


Presentations:
Introducing the Population Standardized Infection Ratio (SIR): A Metric that Marries the Device SIR to the Standardized Utilization Ratio (SUR)
Mohamad Fakih, MD, MPH; Ren-Huai Huang, PhD; Angelo Bufalino, PhD; Lisa Sturm, MPH; Ann Hendrich, PhD, RN; Ziad Haydar, MD, MBA
Methodological Threats to the Standardized Infection and Standardized Antimicrobial Administration Ratios.
Eric Lofgren, MSPH, PhD; Yuliya Lokhnygina, MS, PhD; Rebekah W. Moehring, MD, MPH
Benchmarking Healthcare Associated Infections for Prevention in Developing Countries
Gregory Lauar E Souza, Medical Student; Handerson Dias Duarte De Carvalho, Medical Student; Cristóvão De Deus Martins Oliveira, Medical Student; Andressa Do Nascimento Silveira, Medical Student; Bráulio Couto, PhD; Edna Leite, MD; Estevão Silva, MD; Carlos Starling, Md.
Pilot Implementation of a Nationwide Automated Multidrug-Resistant Organism Tracking and Alert System in Veterans Affairs
Christopher Pfeiffer, MD, MHS; Makoto Jones, MD, MS; J. Stacey Klutts, Md, PhD; Rachael A. Lee, MD; Holly B. Williams, BA; Katelyn A. West, BS; Judith M. Strymish, MD; Nasia Safdar, MD, PhD; Bryan D. Harris, MD, MPH; Michael A. Gelman, MD, PhD; Brooke K. Decker, MD, CIC; Adrienne Murray, PharmD; Nefi Aguilar, MS; Martin E. Evans, MD, FIDSA, FSHEA
Posters
  • IDWeek2018 Poster FINAL.pdf (750.4 kB)
  • Risk Factors for Carbapenem-resistant Gram-Negative Bloodstream Infections (BSI) in US Hospitals (2010-2015)
    Bin Cai, MD, PhD; Roger Echols, MD, FIDSA; Deborah Rudin, MD; Gareth Morgan, BA; Tsutae Nagata, MD, PhD, FFPM
    Risk Factors for CPE Colonization in Household Contacts of CPE Colonized/Infected Patients.
    Lubna Farooqi, MBBS; Amna Faheem, MBBS, MPH; Irene Armstrong, MD; Emily Borgundvaag, MSc; Brenda Coleman, PhD; Karen Green, MSc, RN; Kithsiri Jayasinghe, MSc; Jennie Johnstone, MD, PhD; Kevin Katz, MD, CM, MSc, FRCPC; Philipp Kohler, MD; Angel Li, MSc; Roberto Melano, PhD; Matthew Muller, MD, FRCPC, PhD; Sarah Nayani, PhD; Samir Patel, PhD; Aimee Paterson, MSc; Susan Poutanen, MD, MPH; Anu Rebbapragada, PhD; David Richardson, MD; Alicia Sarabia, MD; Shumona Shafinaz, MD; Andrew E. Simor, MD, FRCPC, FACP; Barbara Willey, ART; Laura Wisely, RT; Zoe Zhong, PhD; Allison McGeer, MD, MSc
    Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) Hospitals, 2018.
    Felipe Garcia Jeldes, MD; Allison McGeer, MD, MSc; Amrita Bharat, PhD; Robyn Mitchell, MHSc
    Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage on Admission using Updated Statewide Hospital Discharge Data
    Michael J. Ray, MPH; William E. Trick, MD; Angela S. Tang, MPH; Michael Y. Lin, MD, MPH
    Posters
  • IDWeek Poster_FINAL.pdf (779.0 kB)
  • Regional Variation in Community-onset and Hospital-Identified Clostridium difficile Infection, 2017
    Katharina Van Santen, MSPH; Jonathan R. Edwards, MStat; Raymund Dantes, MD, MPH
    The National Burden of Pneumonia and Influenza in U.S. Nursing Homes, 2013-2015.
    Kevin Mcconeghy, Pharm.D.; Andrew Zullo, PharmD, M.Sc., Ph.D.; Robertus Van Aalst, M.Sc.; Ayman Chit, Ph.D., MBiotech; Stefan Gravenstein, MD, MPH; Vincent Mor, PhD
    Comparing Surveillance Definitions for Non-Catheter Associated Urinary Tract Infections
    Rupak Datta, MD PhD; Sonali Advani, MBBS, MPH;; Andrea Rink, RN; Luann Bianco, BA; Peter Van Ness, PhD, MPH; Vincent Quagliarello, MD, FIDSA; Manisha Juthani-Mehta, MD, FIDSA, FSHEA
    Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
    Lindsey Groff, BS, PharmD Candidate; Chengwen Teng, PharmD, MS; Victor Encarnacion, PharmD Candidate; Huda Razzack, PharmD Candidate; Obiageri Obodozie-Ofoegbu, BPharm, MSc, PhD; Christopher R. Frei, PharmD, MSc
    Surgical Site Infection Determination in Epic® ICON: A Utilization Model
    Sarah Elizabeth Totten, Dr.PH, M(ASCP); Shane Hansen, MT(ASCP)SC, MSM(IT); Michelle Barron, MD; Larissa Pisney, MD, MSc
    Posters
  • Sarah2.pdf (255.8 kB)
  • In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-lactams Against P. aeruginosa
    Safa Almarzoky Abuhussain, PharmD; Christina Sutherland, BS; David P. Nicolau, PharmD, FCCP, FIDSA
    Use of an Analytic Application for Management of Infection Prevention Data
    Lauren Satchell, BA; Sarah Smathers, MPH, CIC; Katie Williams, MS, BSN, RN; Emily Schriver, MS; Lauren Farrell, MS, MLS(ASCP), CIC; Julia Shaklee Sammons, MD, MSCE
    Detection of Key Potential Healthcare Pathogens Using Periodic Point Prevalence Surveillance
    Donna Schora, MT(ASCP); Michael O. Vernon, DrPH; Adrienne Fisher, MT(ASCP)CIC; Bridget Kufner, MT(ASCP) CIC; Mona Shah, MPH, CIC; Rachel Lim, RN, CIC; Vanida Komutanon, RN, CIC; Crystal Bockoven, MD; Richard Thomson Jr., PhD; Lance Peterson, MD; Kamaljit Singh, MD
    Variability in the Application of Surveillance Definitions for Central Line-Associated Bloodstream Infection Across U.S. Hospitals
    Caitlin Adams Barker, MSN, RN, CIC; Michael Calderwood, MD, MPH; Miriam Dowling-Schmitt, MS, RN, AGNP-C, CCRN
    Posters
  • CLABSI Poster FINAL.pdf (640.0 kB)
  • Incidence and Outcomes of Ventilator Associated Events, Utilising Centre for Disease Control Criteria in a Tertiary Intensive Care Unit, Victoria, Australia.
    David Griffin, BBiomedSc, BSc (Hons), MBBS (Hons), MPH; Irani Thevarajan, MBBS, FRACP, PhD; Simon Iles, MBChB, FRACP, FCICM; Thomas Rechnitzer, MBBS, FCICM; Timothy Spelman, MBBS, FRACGP, PhD; Deborah Barge, BN, CCRN; Caroline Marshall, MBBS, PhD, FRACP, GradDipClinEpi; Nerina Harley, MBBS, MD, PGDipEcho, FRACP, FCICM, AFRACMA; Michael Richards, MBBS, FRACP, MD
    Efficacy of UV-C Disinfection with or without Sodium Hypochlorite Compared to Usual Disinfection of Hospital Environmental Surfaces: Pilot study
    Daniela De La Rosa, MSC; Eric Ochoa Hein, MD; Roxana Trejo González, MD, MPH; Diana Vilar-Compte, MD, MSc; Almudena Laris González, MD; Arturo Galindo-Fraga, MD, MS; Luisa Mariana Guerrero Escudero, MD
    Posters
  • UV-C disinfection.pdf (1.4 MB)
  • Financial Cost, Length of Stay, and Patient Experience Associated with Healthcare Associated Infections Across a 43 Hospital Network
    Rachel Kast, PhD; Cole Grabow, MPH; Michelle Fitch, BA; Sandra Tobar, MSBA BSN; Anurag Malani, MD, FIDSA; Russell Olmsted, MPH, CIC
    Posters
  • TH_IDweek PosterREV_kast.pdf (123.4 kB)
  • Surveillance System of Healthcare-associated Infection in High and Upper-middle Income Countries: A Scoping Review
    Saho Takaya, MD, MSc; Nobuaki Matsunaga, MD, PhD, MPH; Kayoko Hayakawa, MD, PhD; Yuki Moriyama, MD; Yuichi Katanami, MD; Taichi Tajima, RN; Chika Tanaka, RPh; Yuki Kimura, RPh, MPH; Sho Saito, MD; Yoshiki Kusama, MD; Shinichiro Morioka, MD; Yumiko Fujitomo, MD, PhD; Norio Ohmagari, MD, MSc, PhD
    High adherence to contact precautions of patients with multidrug resistant organisms (MDRO) and low in-hospital transmission of MDROs
    Andrea C. Büchler, MD; Marc Dangel, MPH; Sarah Tschudin-Sutter, MD MSc; Andreas F. Widmer, MD, MS
    Effectiveness of a risk-stratified measles post-exposure prophylaxis strategy to prevent nosocomial transmission
    Valerie Xue Fen Seah, BSc(Pharm)(Hons), PharmD; . Yelen, .; Chia Yin Chong, MBBS, M. Med, FRCPCH; Natalie Woon Hui Tan, MBBS, MRCPCH; Koh Cheng Thoon, MBBS, MMed (Paeds), MRCPCH; Chee Fu Yung, MFPHM (UK), FFPHM (UK)

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.